§ 38a-504a

Each individual health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 delivered, issued for delivery, renewed, amended or continued in this state shall provide coverage for the routine patient care costs, as defined in section 38a-504d, associated with clinical trials, in accordance with sections 38a-504b to 38a-504g, inclusive. As used in this section and sections 38a-504b to 38a-504g, inclusive, 'clinical trial' means an organized, systematic, scientific study of therapies, tests or other clinical interventions for purposes of treatment or palliation or therapeutic intervention for the prevention of cancer or disabling or life-threatening chronic diseases in human beings.(P.A. 01-171, S. 8, 25; P.A. 11-19, S. 57; 11-172, S. 1.)History: P.A. 01-171 effective January 1, 2002; P.A. 11-19 inserted 'amended or continued', redefined 'cancer clinical trial' and made a technical change, effective January 1, 2012; P.A. 11-172 inserted 'amended or continued', replaced reference to cancer clinical trials with reference to clinical trials, changed defined term from 'cancer clinical trial' to 'clinical trial' and

P.A. 11-172 inserted 'amended or continued', replaced reference to cancer clinical trials with reference to clinical trials, changed defined term from 'cancer clinical trial' to 'clinical trial' and redefined same, and made technical changes, effective January 1, 2012.See Sec. 38a-542a for similar provisions re group policies.

Each individual health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 delivered, issued for delivery, renewed, amended or continued in this state shall provide coverage for the routine patient care costs, as defined in section 38a-504d, associated with clinical trials, in accordance with sections 38a-504b to 38a-504g, inclusive. As used in this section and sections 38a-504b to 38a-504g, inclusive, 'clinical trial' means an organized, systematic, scientific study of therapies, tests or other clinical interventions for purposes of treatment or palliation or therapeutic intervention for the prevention of cancer or disabling or life-threatening chronic diseases in human beings.(P.A. 01-171, S. 8, 25; P.A. 11-19, S. 57; 11-172, S. 1.)History: P.A. 01-171 effective January 1, 2002; P.A. 11-19 inserted 'amended or continued', redefined 'cancer clinical trial' and made a technical change, effective January 1, 2012; P.A. 11-172 inserted 'amended or continued', replaced reference to cancer clinical trials with reference to clinical trials, changed defined term from 'cancer clinical trial' to 'clinical trial' and

P.A. 11-172 inserted 'amended or continued', replaced reference to cancer clinical trials with reference to clinical trials, changed defined term from 'cancer clinical trial' to 'clinical trial' and redefined same, and made technical changes, effective January 1, 2012.See Sec. 38a-542a for similar provisions re group policies.